In PAD patients with type 2 diabetes, the IL-18 level is significantly higher than in non-diabetic PAD patients [46], which may suggest that IL-18 contributes to the extent of impaired perfusion recovery induced in diabetic patients with PAD. Here, IL18 is linked to peripheral arterial disease.